Global Technologies Ltd (OTC: GTLL) is a holding company operating two early-stage subsidiaries: Primecare Supply, which operates in the 503B pharmaceutical procurement and medical clinic supply chain space, and GTLL Advisory, which provides business transformation and operational consulting to medical spas, clinics, and other health and wellness businesses. Revenue is transactional, generated through pharmaceutical supply procurement and advisory service fees. Total revenues were $3,139,008 for the fiscal year ended June 30, 2025, up from $1,057,685 in fiscal year ended June 30, 2024, a 200% increase. Net revenue after shared revenue deductions was $1,045,671 for fiscal year ended June 30, 2025. The company is registered in Delaware and self-identifies as a smaller reporting company and emerging growth company in its 10-K filed December 30, 2025. Both subsidiaries face competition from established providers with greater financial and operational resources, as well as emerging technology platforms and consulting firms targeting the same markets.

Revenue model

Transactional revenue from pharmaceutical procurement supply chain services through Primecare Supply and consulting fees through GTLL Advisory. Gross revenues of $3,139,008 in fiscal year ended June 30, 2025 are reduced by shared revenue of $2,093,337, yielding net revenue of $1,045,671.

Products and services

Primecare Supply: 503B pharmaceutical procurement and medical clinic supply chain services. GTLL Advisory: business transformation and operational consulting for medical spas, clinics, and health and wellness businesses.

Customers and end markets

Medical spas, clinics, and health and wellness businesses. End markets include the U.S. healthcare and wellness industries. No specific customer concentration data disclosed in the filing excerpts.

Value-chain role

Intermediary in the 503B pharmaceutical supply chain and advisory services provider to health and wellness operators. The company describes itself as early-stage with start-up subsidiaries.

Geographic exposure

United States. Registered agent located in Dover, Delaware. No international operations disclosed in the filing excerpts.

Competitors

Well-established 503B pharmaceutical procurement providers (unnamed in filing), Emerging technology platforms targeting healthcare procurement (unnamed in filing), Consulting firms targeting medical spa and clinic markets (unnamed in filing)

Source: SEC 10-K, filed 2025-12-30

Industry: Radio & Tv Broadcasting & Communications Equipment